Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive L-carnitine supplementation, 2.97g daily, to evaluate its effects on alcohol craving and use Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
Neurology 83 , 10671074 (2014)
While GLP-1 receptor agonists offer advantages for weight loss and diabetes control, they also pose significant risks, including thyroid C-cell tumors, acute pancreatitis, and kidney injury
For many, GLP-1 drugs offer quick relief smaller meals, fast weight loss, better control over cravings
Schedule Your Consultation Today What is Glutathione
An important approach to this area is the inhibition of the chaperone proteins involved in the fungal stress response, and their clients (the molecules they pick up and help keep stable)